Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone
Completed · Phase 4
Conditions studied: Gender Dysphoria, Adolescent
In brief
Recommendations regarding contraceptive counseling and reproductive health differ amongst transgender and gender diverse (TGD) youth compared to cis-gender youth. Limited existing literature demonstrates the need for contraceptive counseling that moves beyond cis- and heteronormative assumptions that start with pregnancy prevention and address concerns at the intersection of gender identity. The Investigator's qualitative study will focus on creating best practices regarding equitable contraceptive counseling for TGD youth. The Investigator will recruit transgender youth who are assigned female at birth, and currently or interested in using depo medroxyprogesterone (DMPA). Through focus groups and semi-structured interviews, the investigator hopes to guide providers in creating best practices and more equitable contraceptive counseling for TGD youth and measure satisfaction of DMPA in TGD youth.
Key facts
- Study ID
- NCT05726903
- Run by
- University of Colorado, Denver
- People needed
- 35
- Starts
- 2022-12-06
- Expected to finish
- 2023-11-17
- Last updated by the study team
- 2026-02-12
Who can join
Age: 15 and older, up to 21. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- between the ages of 15-21,
- currently receiving care at one of the clinic sites, assigned female at birth, identify as transgender or gender diverse , and are currently using or are interested in using DMPA.
You may not qualify if…
- Any contraindications to DMPA (based on any category 3 or 4 recommendations from the CDC MEC guidelines)
Where it is running
- Comprehensive Women's Health Center — Denver, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.